News
Macleods’ Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride) dispersible tablets prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
The following APIs were added:
New Invitation for Expression of Interest (EOI) to manufacturers and suppliers of medicinal products for treatment of hepatitis B and C published
New Invitation for Expression of Interest (EOI) to manufacturers and suppliers of medicinal products for treatment of hepatitis B and C.
Newly prequalified Active Pharmaceutical Ingredient (API)
Molnupiravir (WHOAPI-439) manufactured by Emcure Pharmaceuticals Ltd, has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) u
Newly prequalified Active Pharmaceutical Ingredient (API)
Protionamide (WHOAPI-424) manufactured by Micro Labs Ltd, has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalification proc
First Carbetocin Active Pharmaceutical Ingredient (API) Prequalified
Carbetocin (WHOAPI-423) manufactured by Hemmo Pharmaceuticals Pvt.
Cipla’s ritonavir prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Revised Invitation to Manufacturers of Antimalarial Medicines to Submit an Expression of Interest (EOI) Published
The EOI for artesunate/pyronaridine products is being revised to bring it in line with currently available artesunate/pyronaridine comparator products.
First molnupiravir active pharmaceutical ingredient (API) prequalified
Molnupiravir (WHOAPI-451) manufactured by Divi’s Laboratories Limited has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalif
First human insulins prequalified
The first human insulins have been prequalified by WHO: fast-acting human insulin 100 IU/ml and intermediate-acting human insulin 100 IU/ml from Novo Nordisk A/S.
First molnupiravir generic prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s isoniazid 300mg tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
- TB375 - Isoniazid - 300mg - Tablet - Lupin Ltd - INDIA
1st Invitation to manufacturers of IVDs medical devices used for the qualitative detection of Mycobacterium tuberculosis complex DNA and mutations associated with drug-resistant tuberculosis to apply for WHO prequalification assessment as of 22 September
To support the global effort to end the TB epidemic, through the provision of guidance to interested United Nations (UN) and other agencies and WHO Member States in their procurement decisions,
Mylan’s misoprostol tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Desano’s dolutegravir/lamivudine/tenofovir tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: